Many research studies have reported that breast cancer patients with PIK3CA mutations (Figure 1) have a better prognosis [12], while Sobhani et al. reported a worse prognosis for women with PIK3CA-mutant breast tumors [13]. This evidence concerns the gene PIK3CA and breast carcinoma.